Stay updated on Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial
Sign up to get notified when there's something new on the Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial page.

Latest updates to the Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check13 days agoChange DetectedSite revision updated to v3.4.2 and the old government funding notices (lapse notice and v3.4.1) have been removed. These are administrative changes and do not affect the study details or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedA notice about government funding affecting data currency was added at the top of the page, and the revision version was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedMinor UI and metadata updates were made: a glossary toggle, the 'Last Update Submitted that Met QC Criteria' label, capitalization changes for 'No FEAR Act Data', and a new 'Revision: v3.4.0' tag. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check35 days agoChange DetectedAdded Melanoma to related topics and MedlinePlus Genetics as related topics on the study page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 was added; Melanoma and related topics, including MedlinePlus Genetics and Revision: v3.3.3, were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check63 days agoChange DetectedDifference0.2%

Stay in the know with updates to Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial page.